These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 16400741

  • 21. [First-line treatment with pemetrexed in association with cisplatin in patients with non-operable malignant pleural mesothelioma].
    Burgin M, Gairard-Dory A-, Mennecier B, Molard A, Beretz L, Quoix A-.
    Rev Pneumol Clin; 2009 Apr; 65(2):75-83. PubMed ID: 19375046
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pemetrexed therapy for malignant pleural mesothelioma.
    Puto K, Garey JS.
    Ann Pharmacother; 2005 Apr; 39(4):678-83. PubMed ID: 15755794
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA.
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [Abstract] [Full Text] [Related]

  • 31. Pemetrexed in malignant pleural mesothelioma.
    Gatzemeier U.
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):26-31. PubMed ID: 15655933
    [Abstract] [Full Text] [Related]

  • 32. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
    Ceresoli GL, Zucali PA, Favaretto AG, Grossi F, Bidoli P, Del Conte G, Ceribelli A, Bearz A, Morenghi E, Cavina R, Marangolo M, Parra HJ, Santoro A.
    J Clin Oncol; 2006 Mar 20; 24(9):1443-8. PubMed ID: 16549838
    [Abstract] [Full Text] [Related]

  • 33. New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.
    Scagliotti GV, Selvaggi G.
    Clin Lung Cancer; 2008 Mar 20; 9 Suppl 3():S122-8. PubMed ID: 19419926
    [Abstract] [Full Text] [Related]

  • 34. Overview on ongoing or planned clinical trials in Europe.
    Favaretto A.
    Lung Cancer; 2005 Jul 20; 49 Suppl 1():S117-21. PubMed ID: 15950791
    [Abstract] [Full Text] [Related]

  • 35. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
    Pujol JL, Paul S, Chouaki N, Peterson P, Moore P, Berry DA, Salzberg M.
    J Thorac Oncol; 2007 May 20; 2(5):397-401. PubMed ID: 17473654
    [Abstract] [Full Text] [Related]

  • 36. Pemetrexed safety and pharmacokinetics in patients with third-space fluid.
    Dickgreber NJ, Sorensen JB, Paz-Ares LG, Schytte TK, Latz JE, Schneck KB, Yuan Z, Sanchez-Torres JM.
    Clin Cancer Res; 2010 May 15; 16(10):2872-80. PubMed ID: 20460481
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of pemetrexed in elderly cancer patients: results of an integrated analysis.
    Kulkarni PM, Chen R, Anand T, Monberg MJ, Obasaju CK.
    Crit Rev Oncol Hematol; 2008 Jul 15; 67(1):64-70. PubMed ID: 18358737
    [Abstract] [Full Text] [Related]

  • 38. Second-line chemotherapy for non-small cell lung cancer.
    Shepherd FA.
    Expert Rev Anticancer Ther; 2003 Aug 15; 3(4):435-42. PubMed ID: 12934656
    [Abstract] [Full Text] [Related]

  • 39. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
    Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS, Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.
    J Thorac Oncol; 2006 Jul 15; 1(6):591-601. PubMed ID: 17409924
    [Abstract] [Full Text] [Related]

  • 40. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
    Li L, Razak AR, Hughes A.
    Lung Cancer; 2009 May 15; 64(2):207-10. PubMed ID: 18926592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.